Not Signed In - Alexza Completes Enrollment In AZ-001 Phase IIb Clinical Trial In Patients With Migraine Headaches
Thu, 14 Dec 2006 08:00 AM EST
... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has completed patient enrollment in its Phase IIb clinical trial of AZ-001 (Staccato(R) prochlorperazine) in patients with migraine headaches. AZ-001 is an inhalation product candidate being developed for the acute treatment of migraine headaches. [click link for full article] ...
Related Topics
- Clinical Trials
- Migraine
- Pharmacology
- Trastuzumab
- Psychopharmacology
- Eletriptan
- Headache
- Tarceva
- Wild Yam
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Food Recommendations: South Beach Diet - Phase 2
- Food Recommendations: South Beach Diet - Phase 1
- Bevacizumab Injection
- Clinical Growth Charts
- Clinical Assessment Software Application
- Pain Control
- Headaches
- Tension Headaches
email this page
print this page
bookmark this page
feedback on this page
